PULM Company Profile and Key Details
Pulmatrix, Inc.
PULM Stock Price Chart
Stock Price Today
Pulmatrix, Inc. (PULM) stock declined over -2.13%, trading at $5.98 on NASDAQ, down from the previous close of $6.11. The stock opened at $6.20, fluctuating between $5.95 and $6.20 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma, and in patients with cystic fibrosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.
Company Information
| Employees | 22 |
| Beta | 0.99 |
| Sales or Revenue | $7.30M |
| 5Y Sales Change% | 1.695% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Pulmatrix, Inc. (NASDAQ: PULM) stock price is $5.98 in the last trading session. During the trading session, PULM stock reached the peak price of $6.20 while $5.95 was the lowest point it dropped to. The percentage change in PULM stock occurred in the recent session was -2.13% while the dollar amount for the price change in PULM stock was -$0.13.
The NASDAQ listed PULM is part of Biotechnology industry that operates in the broader Healthcare sector. Pulmatrix, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Margaret M. Wasilewski M.D.
Chief Medical Officer
Mr. David J. Maki J.D.
Advisor
Dr. Alexander M. Klibanov Ph.D.
Founder
Dr. Aidan Curran Ph.D.
Vice President of Research & Scientific Affairs
Mr. Teofilo David Raad MBA
Pres, Chief Executive Officer & Director
Mr. Peter Ludlum CMA, MBA
Interim Chief Financial Officer and Principal Accounting & Financial Officer
PULM's closing price is 285.81% higher than its 52-week low of $1.55 where as its distance from 52-week high of $8.44 is -29.15%.
Number of PULM employees currently stands at 22.
Official Website of PULM is: https://www.pulmatrix.com
PULM could be contacted at phone 781 357 2333 and can also be accessed through its website. PULM operates from 99 Hayden Avenue, Lexington, MA 02421, United States.
PULM stock volume for the day was 19.03K shares. The average number of PULM shares traded daily for last 3 months was 500.09K.
The market value of PULM currently stands at $21.84M with its latest stock price at $5.98 and 3.65M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com